Abstract
Insufficient efficacy and/or specificity of antisense oligonucleotides limit their in vivo usefulness. We demonstrate here that a high-affinity DNA analog, locked nucleic acid (LNA), confers several desired properties to antisense agents. Unlike DNA, LNA/DNA copolymers were not degraded readily in blood serum and cell extracts. However, like DNA, the LNA/DNA copolymers were capable of activating RNase H, an important antisense mechanism of action. In contrast to phosphorothioate-containing oligonucleotides, isosequential LNA analogs did not cause detectable toxic reactions in rat brain. LNA/DNA copolymers exhibited potent antisense activity on assay systems as disparate as a G-protein-coupled receptor in living rat brain and an Escherichia coli reporter gene. LNA-containing oligonucleotides will likely be useful for many antisense applications.
MeSH Terms
Animals
Base Sequence
Biological Transport
Breast Neoplasms
Caudate Nucleus/drug effects
Cerebral Ventricles/drug effects,physiology
Drug Design
Enzyme Activation
Female
Humans
Oligodeoxyribonucleotides, Antisense/chemistry,pharmacokinetics,pharmacology
Putamen/drug effects
Rats
Receptors, Opioid, delta/genetics
Ribonuclease H/drug effects,metabolism
Stereotaxic Techniques
Thionucleotides
Tumor Cells, Cultured
Chemicals
Oligodeoxyribonucleotides, Antisense
Receptors, Opioid, delta
Thionucleotides
Ribonuclease H
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
Wahlestedt C
Center for Genomics Research and Department of Neuroscience, Karolinska Institutet, S-171 77 Stockholm, Sweden.
[email protected]
Salmi P
Good L
Kela J
Johnsson T
Hökfelt T
Broberger C
Porreca F
Lai J
Ren K
Ossipov M
Koshkin A
Jakobsen N
Skouv J
Oerum H
Jacobsen M H
Wengel J
References (28)
28 references, click to expand
-
Keeping the biotechnology of antisense in context.
Nat Biotechnol. 1999 Mar;17(3):209
PMID: 10096271
-
Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.
Mol Pharmacol. 1980 Jan;17(1):79-85
PMID: 6104286
-
A biosynthetic approach for the incorporation of unnatural amino acids into proteins.
Methods Mol Biol. 1998;77:43-73
PMID: 9770661
-
Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
Pain. 1995 Sep;62(3):287-93
PMID: 8657428
-
Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects.
Bioorg Med Chem Lett. 1998 Nov 17;8(22):3269-74
PMID: 9873716
-
Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
J Pharmacol Exp Ther. 1996 Apr;277(1):491-501
PMID: 8613959
-
Antisense oligonucleotide strategies in neuropharmacology.
Trends Pharmacol Sci. 1994 Feb;15(2):42-6
PMID: 8165722
-
Antisense therapeutics.
Curr Opin Chem Biol. 1998 Aug;2(4):519-28
PMID: 9736926
-
A good antisense molecule is hard to find.
Trends Biochem Sci. 1998 Feb;23(2):45-50
PMID: 9538686
-
Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor.
Neuron. 1994 Apr;12(4):805-10
PMID: 8161452
-
Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.
Nature. 1993 May 20;363(6426):260-3
PMID: 8487863
-
Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.
Brain Res Mol Brain Res. 1998 Nov 12;62(1):1-11
PMID: 9795101
-
Fomivirsen.
Drugs. 1999 Mar;57(3):375-80; discussion 381
PMID: 10193689
-
Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.
Science. 1993 Jan 22;259(5094):528-31
PMID: 8380941
-
Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse.
Eur J Pharmacol. 1994 Jun 2;258(1-2):R1-3
PMID: 7925585
-
Studies on the direct spinal action of narcotics in the production of analgesia in the rat.
J Pharmacol Exp Ther. 1977 Aug;202(2):411-28
PMID: 18600
-
Antisense oligonucleotides - the way forward.
Curr Opin Drug Discov Devel. 1999 Mar;2(2):142-6
PMID: 19649940
-
Vitravene--another piece in the mosaic.
Antisense Nucleic Acid Drug Dev. 1998 Aug;8(4):vii-viii
PMID: 9743463
-
Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function.
Biol Chem. 1998 Aug-Sep;379(8-9):1045-52
PMID: 9792437
-
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.
Antimicrob Agents Chemother. 1972 Apr;1(4):283-8
PMID: 4208895
-
Applications of peptide nucleic acids.
Curr Opin Biotechnol. 1999 Feb;10(1):71-5
PMID: 10047504
-
Use of antisense vectors and oligodeoxynucleotides in neuro-oncology.
Pediatr Neurosurg. 1998 Jun;28(6):279-85
PMID: 9782204
-
An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice.
Brain Res Bull. 1996;39(3):185-8
PMID: 8866695
-
Differential effects of intrastriatally infused fully and endcap phosphorothioate antisense oligonucleotides on morphology, histochemistry and prodynorphin expression in rat brain.
Brain Res Mol Brain Res. 2000 Jan 10;75(1):25-45
PMID: 10648885
-
Nucleosides with a twist. Can fixed forms of sugar ring pucker influence biological activity in nucleosides and oligonucleotides?
J Med Chem. 1996 Sep 13;39(19):3739-47
PMID: 8809162
-
Structural studies of LNA:RNA duplexes by NMR: conformations and implications for RNase H activity.
Chemistry. 2000 Aug 4;6(15):2687-95
PMID: 10985717
-
Brain as a unique antisense environment.
Antisense Nucleic Acid Drug Dev. 1999 Feb;9(1):105-16
PMID: 10192296
-
Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
Eur J Pharmacol. 1994 Feb 21;253(1-2):67-73
PMID: 7912199